-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
·In order to meet the growing demand for high-quality pharmaceutical packaging in the domestic market, SCHOTT will invest about 50 million euros (about 380 million yuan) in China.
The new production line is expected to be completed in December 2022, and the design and construction will be implemented thoroughly The concept of energy saving and consumption reduction · SCHOTT glass tube and pharmaceutical packaging production base are built next to each other, Jinyun has become the central hub of SCHOTT's pharmaceutical business in AsiaDecember 7, 2021——SCHOTT AG, a multinational high-tech group, announced its A new round of major investment in the pharmaceutical packaging production line in Jinyun, Zhejiang is another milestone in SCHOTT's investment strategy in China
.
The expansion project, costing around 50 million euros, aims to triple the plant's total capacity
.
"Despite the raging global epidemic, we are very pleased to see that all SCHOTT's expansion projects in China are progressing steadily
.
Our medicinal glass tube plant and pharmaceutical packaging plant are located in Jinyun, so Jinyun has become SCHOTT in Asia.
the central hub of the pharmaceutical business,” said Dr.
He Derui, CEO of SCHOTT Group
.
“This expansion project will further increase production capacity to meet the rising demand for high-quality glass pharmaceutical packaging in the domestic pharmaceutical market,” said Abelardo Riveron, SCHOTT Asia Operations Manager and Managing Director, at the groundbreaking ceremony
.
"At the same time, SCHOTT will further promote the quality upgrade of pharmaceutical packaging in China and help realize the great vision of 'Healthy China 2030'," he added
.
In addition, the second-phase factory will become a model of construction integrating energy-saving technology and green technology
.
In China, SCHOTT supplies billions of pharmaceutical packaging containers every year, including ampoules, injection bottles, cartridges and other glass pharmaceutical packaging for safe storage of medicines, including vaccines and other pharmaceutical packaging
.
SCHOTT has so far invested more than 100 million euros in the production line of pharmaceutical products in China, which is an important part of SCHOTT's global $1 billion investment plan for pharmaceutical business
.
In China's pharmaceutical packaging industry, the design and construction of the SCHOTT factory are at a high level, with highly automated production and visual inspection systems
.
The new project expands the Jinyun factory to 88,000 square meters
.
At present, the Jinyun factory has more than 600 employees and is expected to provide more employment opportunities after the completion of the second phase of the project in 2023
.
Globally, the SCHOTT Group plans to achieve the ambitious goal of climate neutrality by 2030, and has been committed to the implementation of green technology and energy-saving measures in the production process
.
For the design and construction of the new Jinyun project, SCHOTT will use new materials and technologies that are both environmentally friendly and smart, such as: using natural light to reduce indoor lighting, recovering heat from water heating, solar power generation, using LED lighting systems, using Exterior wall materials with high thermal insulation coefficient,
etc.
The design and construction of SCHOTT China's pharmaceutical packaging factory will combine environmental protection concepts and intelligent technology
.
Image source: The second phase of the SCHOTT Medical Systems Zhejiang plant officially laid the foundation stone on December 7, 2021
.
Photo source: Abelardo Riveron, Head of Asian Operations and Managing Director of SCHOTT, signed the third-phase agreement of intent with Lijin High-tech Zone on behalf of SCHOTT
.
Image source: SCHOTT The successful foundation stone laying of the second phase of the Zhejiang plant of SCHOTT Medical Systems will further promote the quality upgrade of pharmaceutical packaging in China and help realize the great vision of 'Healthy China 2030'
.
Image credit: SCHOTT Driving innovation – taking responsibility – creating together.
The three qualities of the SCHOTT Group, a manufacturer of high-tech specialty glass materials, are pioneering, responsibility and solidarity
.
The founder Otto Schott is the leader of the entire glass industry
.
For more than 130 years, SCHOTT's #glasslovers have continued to develop new markets and new territories with a pioneering spirit and boundless passion
.
With offices in 34 countries and regions, the company is a high-tech partner in cutting-edge fields such as medical, home appliances, consumer electronics, semiconductors, data communications, optics, industry, energy, automotive, astronomy, and aerospace
.
In fiscal 2020, the company's 16,500 employees generated a total sales volume of 2.
24 billion euros (17.
442 billion yuan)
.
The SCHOTT Group is backed by a good team and digital tools for continued business growth
.
The SCHOTT Group is part of the Carl Zeiss Foundation, one of the oldest German foundations and uses dividends from the SCHOTT Group to promote science and technology.
As a foundation company, SCHOTT is responsible for its employees, society and the environment.
have special responsibilities
.
The company is committed to becoming carbon neutral by 2030
.
The new production line is expected to be completed in December 2022, and the design and construction will be implemented thoroughly The concept of energy saving and consumption reduction · SCHOTT glass tube and pharmaceutical packaging production base are built next to each other, Jinyun has become the central hub of SCHOTT's pharmaceutical business in AsiaDecember 7, 2021——SCHOTT AG, a multinational high-tech group, announced its A new round of major investment in the pharmaceutical packaging production line in Jinyun, Zhejiang is another milestone in SCHOTT's investment strategy in China
.
The expansion project, costing around 50 million euros, aims to triple the plant's total capacity
.
"Despite the raging global epidemic, we are very pleased to see that all SCHOTT's expansion projects in China are progressing steadily
.
Our medicinal glass tube plant and pharmaceutical packaging plant are located in Jinyun, so Jinyun has become SCHOTT in Asia.
the central hub of the pharmaceutical business,” said Dr.
He Derui, CEO of SCHOTT Group
.
“This expansion project will further increase production capacity to meet the rising demand for high-quality glass pharmaceutical packaging in the domestic pharmaceutical market,” said Abelardo Riveron, SCHOTT Asia Operations Manager and Managing Director, at the groundbreaking ceremony
.
"At the same time, SCHOTT will further promote the quality upgrade of pharmaceutical packaging in China and help realize the great vision of 'Healthy China 2030'," he added
.
In addition, the second-phase factory will become a model of construction integrating energy-saving technology and green technology
.
In China, SCHOTT supplies billions of pharmaceutical packaging containers every year, including ampoules, injection bottles, cartridges and other glass pharmaceutical packaging for safe storage of medicines, including vaccines and other pharmaceutical packaging
.
SCHOTT has so far invested more than 100 million euros in the production line of pharmaceutical products in China, which is an important part of SCHOTT's global $1 billion investment plan for pharmaceutical business
.
In China's pharmaceutical packaging industry, the design and construction of the SCHOTT factory are at a high level, with highly automated production and visual inspection systems
.
The new project expands the Jinyun factory to 88,000 square meters
.
At present, the Jinyun factory has more than 600 employees and is expected to provide more employment opportunities after the completion of the second phase of the project in 2023
.
Globally, the SCHOTT Group plans to achieve the ambitious goal of climate neutrality by 2030, and has been committed to the implementation of green technology and energy-saving measures in the production process
.
For the design and construction of the new Jinyun project, SCHOTT will use new materials and technologies that are both environmentally friendly and smart, such as: using natural light to reduce indoor lighting, recovering heat from water heating, solar power generation, using LED lighting systems, using Exterior wall materials with high thermal insulation coefficient,
etc.
The design and construction of SCHOTT China's pharmaceutical packaging factory will combine environmental protection concepts and intelligent technology
.
Image source: The second phase of the SCHOTT Medical Systems Zhejiang plant officially laid the foundation stone on December 7, 2021
.
Photo source: Abelardo Riveron, Head of Asian Operations and Managing Director of SCHOTT, signed the third-phase agreement of intent with Lijin High-tech Zone on behalf of SCHOTT
.
Image source: SCHOTT The successful foundation stone laying of the second phase of the Zhejiang plant of SCHOTT Medical Systems will further promote the quality upgrade of pharmaceutical packaging in China and help realize the great vision of 'Healthy China 2030'
.
Image credit: SCHOTT Driving innovation – taking responsibility – creating together.
The three qualities of the SCHOTT Group, a manufacturer of high-tech specialty glass materials, are pioneering, responsibility and solidarity
.
The founder Otto Schott is the leader of the entire glass industry
.
For more than 130 years, SCHOTT's #glasslovers have continued to develop new markets and new territories with a pioneering spirit and boundless passion
.
With offices in 34 countries and regions, the company is a high-tech partner in cutting-edge fields such as medical, home appliances, consumer electronics, semiconductors, data communications, optics, industry, energy, automotive, astronomy, and aerospace
.
In fiscal 2020, the company's 16,500 employees generated a total sales volume of 2.
24 billion euros (17.
442 billion yuan)
.
The SCHOTT Group is backed by a good team and digital tools for continued business growth
.
The SCHOTT Group is part of the Carl Zeiss Foundation, one of the oldest German foundations and uses dividends from the SCHOTT Group to promote science and technology.
As a foundation company, SCHOTT is responsible for its employees, society and the environment.
have special responsibilities
.
The company is committed to becoming carbon neutral by 2030
.
